Universidad de Sevilla
Repercusiones en el reservorio viral, fenotipo de linfocitos T y marcadores inflamatorios de la doble terapia comparada con la triple terapia en pacientes con infección por el VIH
Abstract
dc:description.abstractIn this PhD Thesis, we have evaluated the qualitative and quantitative changes in the HIV-1 reservoir in lymphocytes T CD4+, the phenotypic changes in lymphocytes T CD4+ and CD8+, different inflammatory markers, and immune recovery after 12 and 24 months of starting a dual antiretroviral therapy (DT) based on dolutegravir/lamivudine (DTG/3TC) compared with a triple therapy (TT) based on dolutegravir + tenofovir alafenamide/emtricitabine We also compared the viral kinetics in seminal plasma in the same clinical trial between these two treatment arms. Finally, we analyzed the long-term impact on the HIV-1 viral reservoir, immunological parameters, various inflammatory markers, and immune recovery after simplification to DT based on DTG/3TC or darunavir cobicistat + lamivudine (DRVc + 3TC) for ?4 years compared to maintaining a triple therapy (TT) based on bictegravir, tenofovir alafenamide, and emtricitabine (BIC/TAF/FTC). In the three studies, we have shown no differences in any of the parameters analyzed, which clarifies previous doubts about the possible consequences of using these DTs instead of a standard three-drug antiretroviral treatment. These results support using treatments with less drug exposure, potentially less toxic, and at a lower cost.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Saborido Alconchel, Abraham
- Advisors dc:contributor.advisor
-
- López Cortés, Luis Fernando
- Gutiérrez Valencia, Alicia
Rights
dc:rights.accessrights- Statement dc:rights.accessrights
-
- open access
- Attribution-NonCommercial-NoDerivatives 4.0 International
- Licence dc:rights.uri
- Language dc:language.iso
- spa
Identifiers
dc:identifier.*- Dc Identifier Citation
- Saborido Alconchel, A. (2025). Repercusiones en el reservorio viral, fenotipo de linfocitos T y marcadores inflamatorios de la doble terapia comparada con la triple terapia en pacientes con infección por el VIH. (Tesis Doctoral Inédita). Universidad de Sevilla, Sevilla.